These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22050351)

  • 21. Common questions about the diagnosis and management of benign prostatic hyperplasia.
    Pearson R; Williams PM
    Am Fam Physician; 2014 Dec; 90(11):769-74. PubMed ID: 25611711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
    Trachtenberg J
    BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
    Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
    Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manifestations of benign prostatic hyperplasia.
    Madsen FA; Bruskewitz RC
    Urol Clin North Am; 1995 May; 22(2):291-8. PubMed ID: 7539175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [German guidelines for the assessment of BPH. What's new in 2007?].
    Oelke M; Michel MC; Höfner K
    Urologe A; 2008 Feb; 47(2):149-54. PubMed ID: 18210073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign prostatic hyperplasia in older men.
    Gerber GS
    Clin Geriatr Med; 1998 May; 14(2):317-31. PubMed ID: 9536108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign prostatic hypertrophy.
    O'Brien WM
    Am Fam Physician; 1991 Jul; 44(1):162-71. PubMed ID: 1711771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
    Riehmann M; Jønler M; Nordling J; Hald T
    Ugeskr Laeger; 1996 May; 158(20):2853-8. PubMed ID: 8686021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correct nomenclature, symptom score, laboratory values and ultrasound. Your tools for diagnosis of benign prostatic hyperplasia syndrome].
    Menninger M; Hofstetter A
    MMW Fortschr Med; 2002 Apr; 144(16):28-32. PubMed ID: 12043097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign prostatic hyperplasia: a review.
    Ramsey EW
    Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of benign prostatic hyperplasia disease.
    Marks LS; Roehrborn CG; Andriole GL
    J Urol; 2006 Oct; 176(4 Pt 1):1299-306. PubMed ID: 16952616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
    Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.